MRNY Fact Sheet: YieldMax MRNA Option Income Strategy ETF
Share
$33.50
close, Nov 20, 2026
Over the year to Nov 19, 2026, MRNY returned +455.8% in total and charged 1.00% a year.
- 1-year total return
- +480.3%
- MRNA +772.1% to Nov 20, 2026
- Expense ratio
- 1.00%
- a year
- Net assets
- $228m
- on Nov 19, 2026
- Net flow, last 4 trading days
- +$17.1m
- daily basis to Nov 19, 2026
Growth of $10,000, 1 year
MRNY $55,583 +455.8% · MRNA $81,385 +713.9% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.
Returns
WindowTotal return
1 month−21.7%
3 months+23.8%
Year to date+391.8%
1 year+480.3%
3 years+61.2%
Total return, distributions reinvested, each window to Nov 20, 2026.
Facts
Synthetic covered call on MRNA, paying weekly · First traded Oct 24, 2023 · Benchmark Moderna (MRNA)